Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years

Pediatric Blood and Cancer

Volumn 60, Issue 11, 2013, Pages 1792-1797

  Künkele, Annette ^a   Engelhard, Marianne ^b   Hauffa, Berthold P ^a   Mellies, Uwe ^a   Müntjes, Carsten ^a   Hüer, Claudia ^a   Eggert, Angelika ^a   Schulte, Johannes H ^a   Kremens, Bernhard ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Long term sequelae; Pediatric hematopoietic stem cell transplantation; Total body irradiation

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ATYPICAL CHRONIC MYELOID LEUKEMIA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; EWING SARCOMA; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART FUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; MYELOFIBROSIS; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; REMISSION; SCHOOL CHILD; TREATMENT DURATION; WHOLE BODY RADIATION;

LONG-TERM SEQUELAE; PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; TOTAL BODY IRRADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEOPLASMS; SURVIVORS; TIME; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84883782036     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24702     Document Type: Article

References (50)

1. Thomas ED. A history of haemopoietic cell transplantation. Br J Haematol 1999; 105:330-339.
2. Goldman JM, Schmitz N, Niethammer D, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21:1-7.
3. Ringden O, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93:637-645.
4. Davies SM, Ramsay NK, Klein JP, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000; 18:340-347.
5. Frisk P, Bratteby LE, Carlson K, et al. Renal function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2002; 29:129-136.
6. Hows JM, Passweg JR, Tichelli A, et al. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant 2006; 38:799-805.
7. Mayer EI, Dopfer RE, Klingebiel T, et al. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant 1999; 3:38-44.
8. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001; 28:283-287.
9. Blume KG, Forman SJ, O'Donnell MR, et al. Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69:1015-1020.
10. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100:680-687.
11. Guinan EC, Tarbell NJ, Niemeyer CM, et al. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72:451-455.
12. Lawton CA, Cohen EP, Barber-Derus SW, et al. Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 1991; 67:2795-2800.
13. Lawton CA, Cohen EP, Murray KJ, et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 1997; 20:1069-1074.
14. Moulder JE, Fish BL. Age dependence of radiation nephropathy in the rat. Radiat Res 1997; 147:349-353.
15. Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008; 41:223-227.
16. Bunin N, Aplenc R, Kamani N, et al. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 2003; 32:543-548.
17. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338.
18. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511-522.
19. Hermanussen M, Cole J. The calculation of target height reconsidered. Horm Res 2003; 59:180-183.
20. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde 2001; 149:807-818.
21. Cole TJ. Extreme percentiles of the 2000 Centers for Disease Control and Prevention BMI chart and the LMS method. Am J Clin Nutr 2010; 91:814, author reply 815-816.
22. Reinken L, van Oost G. Longitudinal physical development of healthy children 0 to 18 years of age. Body length/height, body weight and growth velocity. Klin Padiatr 1992; 204:129-133.
23. Blaise D, Maraninchi D, Archimbaud E, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: A report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 1992; 79:2578-2582.
24. Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83:2723-2730.
25. Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: A meta-analysis. Bone Marrow Transplant 1998; 22:439-443.
26. Socie G, Clift RA, Blaise D, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: Long-term follow-up of 4 randomized studies. Blood 2001; 98:3569-3574.
27. Bhatia S, Robison LL, Francisco L, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: Report from the Bone Marrow Transplant Survivor Study. Blood 2005; 105:4215-4222.
28. Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19:2130-2138.
29. Lazarus HM, Perez WS, Klein JP, et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: A retrospective analysis from the Center for International Blood and Marrow Transplant Research. Br J Haematol 2006; 132:755-769.
30. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005; 19:2101-2116.
31. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324:808-815.
32. Baello EB, Ensberg ME, Ferguson DW, et al. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep 1986; 70:1187-1193.
33. Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: A prospective evaluation of new dosing regimens. J Clin Oncol 1991; 9:1215-1223.
34. Bearman SI, Petersen FB, Schor RA, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: Risk for cardiac toxicity. Bone Marrow Transplant 1990; 5:173-177.
35. Cazin B, Gorin NC, Laporte JP, et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 1986; 57:2061-2069.
36. Wolford JL, McDonald GB. A problem-oriented approach to intestinal and liver disease after marrow transplantation. J Clin Gastroenterol 1988; 10:419-433.
37. Day DL, Carpenter BL. Abdominal complications in pediatric bone marrow transplant recipients. Radiographics 1993; 13:1101-1112.
38. Brennan BM, Shalet SM. Endocrine late effects after bone marrow transplant. Br J Haematol 2002; 118:58-66.
39. Chemaitilly W, Boulad F, Heller G, et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007; 40:29-35.
40. Bakker B, Oostdijk W, Geskus RB, et al. Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood. Pediatr Res 2006; 59:259-264.
41. Jung MH, Cho KS, Lee JW, et al. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. J Korean Med Sci 2009; 24:1071-1077.
42. Bakker B, Massa GG, Oostdijk W, et al. Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000; 159:31-37.
43. Chow EJ, Simmons JH, Roth CL, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant 2010; 16:1674-1681.
44. Holm K, Nysom K, Rasmussen MH, et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996; 18:163-170.
45. Ogilvy-Stuart AL, Clark DJ, Wallace WH, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992; 67:1107-1110.
46. Boulad F, Bromley M, Black P, et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15:71-76.
47. Toubert ME, Socie G, Gluckman E, et al. Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. Br J Haematol 1997; 98:453-457.
48. Slatter MA, Gennery AR, Cheetham TD, et al. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 2004; 33:949-953.
49. Shalet SM, Hann IM, Lendon M, et al. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child 1981; 56:275-278.
50. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin Hematol 1991; 28:244-249.